Abiraterone Qilu 500 mg Norge - norska - Statens legemiddelverk

abiraterone qilu 500 mg

qilu pharma spain s.l. - abirateronacetat - tablett, filmdrasjert - 500 mg

Cinacalcet STADA 30 mg Norge - norska - Statens legemiddelverk

cinacalcet stada 30 mg

stada arzneimittel ag - cinacalcethydroklorid - tablett, filmdrasjert - 30 mg

Cinacalcet STADA 60 mg Norge - norska - Statens legemiddelverk

cinacalcet stada 60 mg

stada arzneimittel ag - cinacalcethydroklorid - tablett, filmdrasjert - 60 mg

Cinacalcet STADA 90 mg Norge - norska - Statens legemiddelverk

cinacalcet stada 90 mg

stada arzneimittel ag - cinacalcethydroklorid - tablett, filmdrasjert - 90 mg

Zyrtec 10 mg Norge - norska - Statens legemiddelverk

zyrtec 10 mg

ucb nordic as - cetirizindihydroklorid - tablett, filmdrasjert - 10 mg

Zilas 20 mg Norge - norska - Statens legemiddelverk

zilas 20 mg

menarini international o.l. sa - bilastin - tablett - 20 mg

Letifend Europeiska unionen - norska - EMA (European Medicines Agency)

letifend

leti pharma, s.l.u. - recombinant protein q from leishmania infantum mon-1 - inaktivert bakteriell vaksiner (inkludert mycoplasma, toxoid og klamydia) - hunder - for aktiv immunisering av hunder fra 6 måneder for å redusere risikoen for å utvikle et klinisk tilfelle av leishmaniasis.

Tivicay Europeiska unionen - norska - EMA (European Medicines Agency)

tivicay

viiv healthcare bv - dolutegravir - hiv-infeksjoner - antivirale midler til systemisk bruk - tivicay is indicated in combination with other anti-retroviral medicinal products for the treatment of human immunodeficiency virus (hiv) infected adults, adolescents and children of at least 6 years of age or older and weighing at least 14 kg. tivicay is indicated in combination with other anti-retroviral medicinal products for the treatment of human immunodeficiency virus (hiv) infected adults, adolescents and children of at least 4 weeks of age or older and weighing at least 3 kg.

Triumeq Europeiska unionen - norska - EMA (European Medicines Agency)

triumeq

viiv healthcare b.v. - dolutegravir sodium, lamivudine, abacavir (as sulfate) - hiv-infeksjoner - antivirale midler til systemisk bruk - triumeq is indicated for the treatment of human immunodeficiency virus (hiv) infected adults,  adolescents and children  weighing at least 25 kg who are antiretroviral treatment-naïve or are infected with hiv without documented or clinically suspected resistance to any of the three antiretroviral agents in triumeq.

Juluca Europeiska unionen - norska - EMA (European Medicines Agency)

juluca

viiv healthcare b.v. - dolutegravir natrium, rilpivirine hydrochloride - hiv-infeksjoner - antivirale midler til systemisk bruk - juluca er angitt for behandling av humant immunsviktvirus type 1 (hiv-1) - infeksjon hos voksne som er virologically-undertrykket (hiv-1 rna.